ArticleFrontiers in neurology
Developing an integrated brain resource framework for translational neuroscience in Korea Brain Bank.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The Korea Brain Research Institute (KBRI) and its core facility, the Korea Brain Bank (KBB), are establishing a national framework that integrates human brain banking with digital and multi-omics resources to strengthen translational neuroscience in Korea. Operating under the Brain Research Promotion Act (BRPA) and supported by the Ministry of Science and ICT (MSIT), the KBB manages the designated Korean Brain Bank Network (KBBN), a national system that provides centrally coordinated nationwide coverage through eight network hospitals. The network is supported by the KBRI-developed Brain Resource Archive Management System (BRAMS) for integrated management of human brain resources. KBBN enhances interoperability, standardization, and data accessibility across the network. These efforts have led to measurable improvements in data completeness, resource utilization efficiency, and research connectivity. Since its establishment, KBBN has prioritized the collection of brain resources from patients with neurodegenerative disorders, enabling neuropathological assessment and digital dataset construction for integrated analysis. However, securing brain resources for psychiatric disorders remains limited due to sociocultural barriers to donation in Korea. To address this, KBB is expanding international collaboration to develop specialized psychiatric cohorts for joint multi-omics studies. Future strategies focus on increasing functional resource value through single-cell and spatial omics integration, linking postmortem-derived iPSC and organoid models, and establishing an AI-assisted federated data governance system that integrates imaging, genomic, and clinical data within a Brain Atlas Hub. Through the convergence of cellular innovation, digital governance, and global cooperation, KBB seeks to advance responsible and sustainable brain resource management in Korea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.